U.S. FDA Issues Complete Response Letter for Baricitinib
Go back to U.S. FDA Issues Complete Response Letter for Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 103.19 +4.97 (5.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.22 | 52 Week High | $118.49 | |||
| Open | $99.79 | 52 Week Low | $55.00 | |||
| Day High | $103.47 | P/E | N/A | |||
| Day Low | $99.79 | EPS | $-0.56 | |||
| Volume | 887,220 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1105.16 +6.59 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.82 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 1,515,912 | |||||
